EV/EBITDA
-10.87
+0.29+2.60%
4 min ago
Summary
- As of February 7, 2025, CRSP EV/EBITDA is -10.87, with a rise of +0.29 (+2.60%) during the most recent trading day.
- Over the past year, CRSP EV/EBITDA has increased by +14.39 (+56.97%).
- CRSP EV/EBITDA is now -100.51% below its all-time high of 2149.62.
Performance
CRSP EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
CRSP EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +2.6% | -2.6% | -2.6% |
| 1 m1 month | +5.6% | -5.7% | -5.7% |
| 3 m3 months | +23.7% | -23.7% | -23.8% |
| 6 m6 months | +3.7% | -10.1% | -15.9% |
| ytdytd | -1.3% | +1.3% | +1.3% |
| 1 y1 year | +57.0% | -33.5% | -39.5% |
| 5 y5 years | -124.4% | +48.4% | -23.9% |
CRSP EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -3.7% | -12.14 | +10.5% | |
| 3 m | 3-month | -10.48 | -3.7% | -15.14 | +28.2% |
| 6 m | 6-month | -10.48 | -3.7% | -15.14 | +28.2% |
| 1 y | 1-year | -10.48 | -3.7% | -36.33 | +70.1% |
| 3 y | 3-year | 15.82 | -168.7% | -36.33 | +70.1% |
| 5 y | 5-year | 2149.62 | -100.5% | -49.83 | +78.2% |
| alltime | all time | 2149.62 | -100.5% | -732.31 | +98.5% |
CRISPR Therapeutics AG EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -10.87(+1.3%) |
| 2024 | -10.73(-55.4%) |
| 2023 | -24.05(+371.6%) |
| 2022 | -5.10(-138.9%) |
| 2021 | 13.12(-144.4%) |
| Date | Value |
|---|---|
| 2020 | -29.57(-154.1%) |
| 2019 | 54.62(-928.8%) |
| 2018 | -6.59(-43.1%) |
| 2017 | -11.58(-67.5%) |
| 2016 | -35.60 |
FAQ
- What is CRISPR Therapeutics AG EV/EBITDA?
- What is the all time high EV/EBITDA for CRISPR Therapeutics AG?
- What is CRSP EV/EBITDA year-to-date change?
- What is CRISPR Therapeutics AG EV/EBITDA year-on-year change?
What is CRISPR Therapeutics AG EV/EBITDA?
The current EV/EBITDA of CRSP is -10.87
What is the all time high EV/EBITDA for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high EV/EBITDA is 2149.62
What is CRSP EV/EBITDA year-to-date change?
CRISPR Therapeutics AG EV/EBITDA has changed by -0.14 (-1.30%) since the beginning of the year
What is CRISPR Therapeutics AG EV/EBITDA year-on-year change?
Over the past year, CRSP EV/EBITDA has changed by +14.39 (+56.97%)